임신 중 경증 만성 고혈압에 대한 최신 치료 지침 및 항고혈압 요법
Current Treatment Guidelines and Antihypertensive Therapy of Mild Chronic Hypertension During Pregnancy Tae Gyu Ahn · Jong Yun Hwang
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Up to 5% of pregnant females experience chronic hypertension, which is linked to poor pregnancy outcomes, and along with hemorrhage, is considered one of the main causes of maternal morbidity and mortality. The combined occurrence of preeclampsia, cesarean sections, preterm birth, birth weight less than 2,500 g, neonatal unit admission, and perinatal death was higher in females with chronic hypertension. Pregnancy with systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg was considered to have mild-to-moderate chronic hypertension. Blood pressure management during pregnancy is a very important issue and is directly related to fetal growth and maternal health. Many studies have reported that antihypertensive therapy during pregnancy halves the incidence of severe hypertension in all types of hypertensive diseases. However, guidelines for optimal blood pressure management goals during pregnancy remain unclear. This is because the benefits to the mother from lowering blood pressure are uncertain, and there is a risk of fetal disorders due to the possibility of reduced uteroplacental blood flow. In light of a recently released CHAP (Chronic Hypertension and Pregnancy) randomized controlled trial, the purpose of this review was to provide a summary of the current recommendations for pregnant females with mild-to-moderate chronic hypertension.
Abstract
Up to 5% of pregnant females experience chronic hypertension, which is linked to poor pregnancy outcomes, and along with hemorrhage, is considered one of the main causes of maternal morbidity and mortality. The combined occurrence of preeclampsia, cesarean sections, preterm birth, birth weight less than 2,500 g, neonatal unit admission, and perinatal death was higher in females with chronic hypertension. Pregnancy with systolic blood pressure of 140-159 mmHg or diastolic blood pressure of 90-109 mmHg was considered to have mild-to-moderate chronic hypertension. Blood pressure management during pregnancy is a very important issue and is directly related to fetal growth and maternal health. Many studies have reported that antihypertensive therapy during pregnancy halves the incidence of severe hypertension in all types of hypertensive diseases. However, guidelines for optimal blood pressure management goals during pregnancy remain unclear. This is because the benefits to the mother from lowering blood pressure are uncertain, and there is a risk of fetal disorders due to the possibility of reduced uteroplacental blood flow. In light of a recently released CHAP (Chronic Hypertension and Pregnancy) randomized controlled trial, the purpose of this review was to provide a summary of the current recommendations for pregnant females with mild-to-moderate chronic hypertension.
참고문헌 (31)
- Abalos E, "Antihypertensive drug therapy for mild to moderate hypertension during pregnancy", Cochrane Database Syst Rev, (2), pp.CD002252~ (2014)
- Abalos E, "Antihypertensive drug therapy for mild to moderate hypertension during pregnancy", Cochrane Database Syst Rev, 10, pp.CD002252~ (2018)
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics, "ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy", Obstet Gynecol, 133, pp.e26~50 (2019)
- American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, "Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy", Obstet Gynecol, 122, pp.1122~1131 (2013)
- Brown MA, "Hypertensive disorders of pregnancy : ISSHP classification, diagnosis, and management recommendations for international practice", Hypertension, 72, pp.24~43 (2018)
- Butalia S, "Hypertension Canada's 2018 Guidelines for the management of hypertension in pregnancy", Can J Cardiol, 34, pp.526~531 (2018)
- Chiriacò M, "Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes : a systematic review and meta-analysis", Diabetes Obes Metab, 21, pp.2587~2598 (2019)
- Choi YJ, "Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events : a nationwide population-based study from Korea", Eur Heart J, 40, pp.724~731 (2019)
- Churchill D, "Diuretics for preventing pre-eclampsia", Cochrane Database Syst Rev, 2007, pp.CD004451~ (2007)
- Clark SL, "Preventing maternal death : 10 clinical diamonds", Obstet Gynecol, 119(2 Pt 1), pp.360~364 (2012)
- Collins R, "Overview of randomised trials of diuretics in pregnancy", Br Med J(Clin Res Ed), 290, pp.17~23 (1985)
- Duley L, "Drugs for treatment of very high blood pressure during pregnancy", Cochrane Database Syst Rev, 2013, pp.CD001449~ (2013)
- European Society of Gynecology (ESG), "ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)", Eur Heart J, 32, pp.3147~3197 (2011)
- Fitton CA, "In-utero exposure to antihypertensive medication and neonatal and child health outcomes : a systematic review", J Hypertens, 35, pp.2123~2137 (2017)
- Gruppo di Studio Ipertensione in Gravidanza, "Nifedipine versus expectant management in mild to moderate hypertension in pregnancy", Br J Obstet Gynaecol, 105, pp.718~722 (1998)
- Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies", Lancet, 360, pp.1903~1913 (2002)
- Lopes Perdigao J, "Furosemide for accelerated recovery of blood pressure postpartum in women with a hypertensive disorder of pregnancy : a randomized controlled trial", Hypertension, 77, pp.1517~1524 (2021)
- Lydakis C, "Atenolol and fetal growth in pregnancies complicated by hypertension", Am J Hypertens, 12, pp.541~547 (1999)
- Magee LA, "Fortnightly review : management of hypertension in pregnancy", BMJ, 318, pp.1332~1336 (1999)
- Magee LA, "Less-tight versus tight control of hypertension in pregnancy", N Engl J Med, 372, pp.407~417 (2015)
- Magee LA, "The CHIPS randomized controlled trial(Control of Hypertension in Pregnancy Study) : is severe hypertension just an elevated blood pressure?", Hypertension, 68, pp.1153~1159 (2016)
- Moser M, "Hypertension in pregnancy : is it time for a new approach to treatment?", J Hypertens, 30, pp.1092~1100 (2012)
- (2019)[URL]
- Pels A, "Influence of gestational age at initiation of antihypertensive therapy : secondary analysis of CHIPS trial data(Control of Hypertension in Pregnancy Study)", Hypertension, 71, pp.1170~1177 (2018)
- Sibai BM, "A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy", Am J Obstet Gynecol, 162, pp.960~966 (1990)
- Sinkey RG, "Prevention, diagnosis, and management of hypertensive disorders of pregnancy : a comparison of international guidelines", Curr Hypertens Rep, 22, pp.66~ (2020)
- SMFM Publications Committee, "Electronic address: pubs@smfm.org. SMFM Statement: benefit of antihypertensive therapy for mildto- moderate chronic hypertension during pregnancy remains uncertain", Am J Obstet Gynecol, 213, pp.3~4 (2015)
- Society for Maternal-Fetal Medicine, "Society for Maternal-Fetal Medicine Statement: antihypertensive therapy for mild chronic hypertension in pregnancy-The Chronic Hypertension and Pregnancy trial", Am J Obstet Gynecol, 227, pp.B24~ (2022)
- Tita AT, "Treatment for mild chronic hypertension during pregnancy", N Engl J Med, 386, pp.1781~1792 (2022)
- von Dadelszen P, "Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension : a meta-analysis", Lancet, 355, pp.87~92 (2000)
- "WHO recommendations: drug treatment for severe hypertension in pregnancy" (2018)[URL]